ALDR
Alder Biopharmaceuticals
ALDR
ALDR
Delisted
ALDR was delisted on the 21st of October, 2019.
128 hedge funds and large institutions have $1.19B invested in Alder Biopharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 44 increasing their positions, 44 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
42% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 26
57% less call options, than puts
Call options by funds: $2.08M | Put options by funds: $4.78M
Holders
128
Holding in Top 10
4
Calls
$2.08M
Puts
$4.78M
Top Buyers
| 1 | +$89.2M | |
| 2 | +$15.4M | |
| 3 | +$10.5M | |
| 4 |
Man Group
London,
United Kingdom
|
+$5.99M |
| 5 |
SC
Samlyn Capital
New York
|
+$4.66M |
Top Sellers
| 1 | -$21.5M | |
| 2 | -$18.7M | |
| 3 | -$12.7M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$8.64M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$7.73M |